Examining the Clinical Use of Hemochromatosis Genetic Testing

Examining the Clinical Use of Hemochromatosis Genetic Testing

BACKGROUND: Hereditary hemochromatosis leads to an increased lifetime risk for end-organ damage due to excess iron deposition. Guidelines recommend that genetic testing be performed in patients with clinical suspicion of iron overload accompanied by elevated serum ferritin and transferrin saturation...

Full description

Bibliographic Details
Main Authors: Matthew B Lanktree, Bruce B Lanktree, Guillaume Paré, John S Waye, Bekim Sadikovic, Mark A Crowther
Format: Article
Language:English
Published: Hindawi Limited 2015-01-01
Series:Canadian Journal of Gastroenterology and Hepatology
Online Access:http://dx.doi.org/10.1155/2015/941406
id doaj-ac8db11b2289438d9dadc3bf972cbda4
record_format Article
spelling doaj-ac8db11b2289438d9dadc3bf972cbda42020-11-24T22:52:02ZengHindawi LimitedCanadian Journal of Gastroenterology and Hepatology2291-27892291-27972015-01-01291414510.1155/2015/941406Examining the Clinical Use of Hemochromatosis Genetic TestingMatthew B Lanktree0Bruce B Lanktree1Guillaume Paré2John S Waye3Bekim Sadikovic4Mark A Crowther5Department of Medicine, McMaster University, Hamilton, Ontario, CanadaDepartment of Medicine, McMaster University, Hamilton, Ontario, CanadaDepartment of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, CanadaDepartment of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, CanadaDepartment of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, CanadaDepartment of Medicine, McMaster University, Hamilton, Ontario, CanadaBACKGROUND: Hereditary hemochromatosis leads to an increased lifetime risk for end-organ damage due to excess iron deposition. Guidelines recommend that genetic testing be performed in patients with clinical suspicion of iron overload accompanied by elevated serum ferritin and transferrin saturation levels.http://dx.doi.org/10.1155/2015/941406
collection DOAJ
language English
format Article
sources DOAJ
author Matthew B Lanktree
Bruce B Lanktree
Guillaume Paré
John S Waye
Bekim Sadikovic
Mark A Crowther
spellingShingle Matthew B Lanktree
Bruce B Lanktree
Guillaume Paré
John S Waye
Bekim Sadikovic
Mark A Crowther
Examining the Clinical Use of Hemochromatosis Genetic Testing
Canadian Journal of Gastroenterology and Hepatology
author_facet Matthew B Lanktree
Bruce B Lanktree
Guillaume Paré
John S Waye
Bekim Sadikovic
Mark A Crowther
author_sort Matthew B Lanktree
title Examining the Clinical Use of Hemochromatosis Genetic Testing
title_short Examining the Clinical Use of Hemochromatosis Genetic Testing
title_full Examining the Clinical Use of Hemochromatosis Genetic Testing
title_fullStr Examining the Clinical Use of Hemochromatosis Genetic Testing
title_full_unstemmed Examining the Clinical Use of Hemochromatosis Genetic Testing
title_sort examining the clinical use of hemochromatosis genetic testing
publisher Hindawi Limited
series Canadian Journal of Gastroenterology and Hepatology
issn 2291-2789
2291-2797
publishDate 2015-01-01
description BACKGROUND: Hereditary hemochromatosis leads to an increased lifetime risk for end-organ damage due to excess iron deposition. Guidelines recommend that genetic testing be performed in patients with clinical suspicion of iron overload accompanied by elevated serum ferritin and transferrin saturation levels.
url http://dx.doi.org/10.1155/2015/941406
work_keys_str_mv AT matthewblanktree examiningtheclinicaluseofhemochromatosisgenetictesting
AT bruceblanktree examiningtheclinicaluseofhemochromatosisgenetictesting
AT guillaumepare examiningtheclinicaluseofhemochromatosisgenetictesting
AT johnswaye examiningtheclinicaluseofhemochromatosisgenetictesting
AT bekimsadikovic examiningtheclinicaluseofhemochromatosisgenetictesting
AT markacrowther examiningtheclinicaluseofhemochromatosisgenetictesting
_version_ 1725667520537427968

Similar Items